NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Since the early 1990s it has been postulated that hypofunction of N-methyl-D-aspartate (NMDA) receptors in brain networks supporting perception and cognition underlies schizophrenic psychosis. Recently, NMDA receptor hypofunction was described in patients with psychotic manifestations who exhibited autoantibodies binding the GluN1 subunit of the receptor, and who improved when the level of these antibodies was lowered by immunomodulation. In this disorder, NMDA receptor antibodies decrease the availability of NMDA receptors by internalizing them. Here we review this mechanism as well as data supporting or refuting the possibility that this disorder, or similar autoimmune disorders affecting synaptic proteins which are therefore treatable with immunomodulation, could account for some cases of idiopathic psychosis. We also suggest methodological approaches to clarify this issue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Self-citationKrystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165
Self-citationRecent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
De novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617
Granerod, J., Ambrose, H. E., Davies, N. W., Clewley, J. P., Walsh, A. L., Morgan, D., Cunningham, R., Zuckerman, M., Mutton, K. J., Solomon, T., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70222-x · Cited by 1,358
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders
Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2153 · Cited by 1,159
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Self-citationKapur, S., Zipursky, R., Jones, C., Remington, G., & Houle, S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.514 · Cited by 1,090
Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926
Sex differences in schizophrenia
Abel, K. M., Drake, R., & Goldstein, J. M. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.515205 · Cited by 762
Gable, M. S., Sheriff, H., Dalmau, J., Tilley, D. H., & Glaser, C. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1038 · Cited by 733
Self-citationKendler, K. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110060007 · Cited by 676
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., Weinberger, D. R., & Berman, K. F. (2002) · Nature Neuroscience · doi:10.1038/nn804 · Cited by 652
Self-citationFillman, S. G., Cloonan, N., Catts, V. S., Miller, L. C., Wong, J., McCrossin, T., Cairns, M., & Weickert, C. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.110 · Cited by 609
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565
Synaptic dysregulation in a human iPS cell model of mental disorders
Wen, Z., Nguyen, H. N., Guo, Z., Lalli, M. A., Wang, X., Su, Y., Kim, N.-S., Yoon, K.-J., Shin, J., Zhang, C., et al. (2014) · Nature · doi:10.1038/nature13716 · Cited by 549
Neuronal autoantigens—pathogenesis, associated disorders and antibody testing
Lancaster, E., & Dalmau, J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.99 · Cited by 512
Self-citationWang, M., Yang, Y., Wang, C.-J., Gamo, N. J., Jin, L. E., Mazer, J. A., Morrison, J. H., Wang, X.-J., & Arnsten, A. F. T. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.032 · Cited by 489
Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia
Javitt, D. C., & Freedman, R. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13121691 · Cited by 403
Hammer, C., Stepniak, B., Schneider, A., Papiol, S., Tantra, M., Begemann, M., Sirén, A.-L., Pardo, L. A., Sperling, S., Mohd Jofrry, S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.110 · Cited by 342
Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis
Mikasova, L., De Rossi, P., Bouchet, D., Georges, F., Rogemond, V., Didelot, A., Meissirel, C., Honnorat, J., & Groc, L. (2012) · Brain · doi:10.1093/brain/aws092 · Cited by 341
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients
Pilowsky, L. S., Bressan, R. A., Stone, J. M., Erlandsson, K., Mulligan, R. S., Krystal, J. H., & Ell, P. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001751 · Cited by 278
Influence of GluN2 subunit identity on NMDA receptor function
Wyllie, D. J. A., Livesey, M. R., & Hardingham, G. E. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.016 · Cited by 260
Anticevic, A., Gancsos, M., Murray, J. D., Repovs, G., Driesen, N. R., Ennis, D. J., Niciu, M. J., Morgan, P. T., Surti, T. S., Bloch, M. H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208494109 · Cited by 243
Fusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M.-C., Montgomery, A. J., Grasby, P. M., & McGuire, P. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.108 · Cited by 207
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Slifstein, M., Javitt, D. C., Lieberman, J. A., Abi-Dargham, A., & Girgis, R. R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.136 · Cited by 205
Translating the MAM model of psychosis to humans
Modinos, G., Allen, P., Grace, A. A., & McGuire, P. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2014.12.005 · Cited by 165
Rodríguez-Santiago, B., Brunet, A., Sobrino, B., Serra-Juhé, C., Flores, R., Armengol, L., Vilella, E., Gabau, E., Guitart, M., Guillamat, R., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.53 · Cited by 88
de Souza Silva, M. A., Huston, J. P., Wang, A.-L., Petri, D., & Chao, O. Y.-H. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhv112 · Cited by 41
Research works printed but not linked: 70
- Hansen, 2014, Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors, Neuron, 81, 1084, 10.1016/j.neuron.2014.01.035 · DOI · Paper page
- Karakas, 2014, Crystal structure of a heterotetrameric NMDA receptor ion channel, Science, 344, 992, 10.1126/science.1251915 · DOI · Paper page
- Lee, 2014, NMDA receptor structures reveal subunit arrangement and pore architecture, Nature, 511, 191, 10.1038/nature13548 · DOI · Paper page
- Pachernegg, 2012, GluN3 subunit-containing NMDA receptors: not just one-trick ponies, Trends Neurosci., 35, 240, 10.1016/j.tins.2011.11.010 · DOI
- Wang, 2015, Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates, Neurosci. Bull., 31, 191, 10.1007/s12264-014-1504-6 · DOI · Paper page
- Viaccoz, 2014, Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis, Neurology, 82, 556, 10.1212/WNL.0000000000000126 · DOI · Paper page
- Pathmanandavel, 2015, Antibodies to surface dopamine-2 receptor and N-methyl-d-aspartate receptor in the first episode of acute psychosis in children, Biol. Psychiatry, 77, 537, 10.1016/j.biopsych.2014.07.014 · DOI
- Kayser, 2013, Frequency and characteristics of isolated psychiatric episodes in anti- N-methyl-d-aspartate receptor encephalitis, JAMA Neurol., 70, 1133, 10.1001/jamaneurol.2013.3216 · DOI · Paper page
- Zandi, 2011, Disease-relevant autoantibodies in first episode schizophrenia, J. Neurol., 258, 686, 10.1007/s00415-010-5788-9 · DOI · Paper page
- Jablensky, 2000, Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders, Aust. N. Z. J. Psychiatry, 34, 221, 10.1080/j.1440-1614.2000.00728.x · doi:10.1080/j.1440-1614.2000.00728.x · Paper page
- de Witte, 2015, Absence of N-methyl-d-aspartate receptor IgG autoantibodies in schizophrenia: the importance of cross-validation studies, JAMA Psychiatry, 72, 731, 10.1001/jamapsychiatry.2015.0526 · doi:10.1001/jamapsychiatry.2015.0526
- Masdeu, 2012, Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia, Am. J. Psychiatry, 169, 1120, 10.1176/appi.ajp.2012.12050646 · DOI · Paper page
- Rhoads, 2011, Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia, Schizophr. Res., 129, 213, 10.1016/j.schres.2010.12.018 · DOI
- Steiner, 2013, Increased prevalence of diverse N-methyl-d-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-d-aspartate glutamate receptor encephalitis, JAMA Psychiatry, 70, 271, 10.1001/2013.jamapsychiatry.86 · DOI · Paper page
- Dahm, 2014, Seroprevalence of autoantibodies against brain antigens in health and disease, Ann. Neurol., 76, 82, 10.1002/ana.24189 · DOI · Paper page
- Eisenberg, 2010, Catechol-O-methyltransferase valine158methionine genotype and resting regional cerebral blood flow in medication-free patients with schizophrenia, Biol. Psychiatry, 67, 287, 10.1016/j.biopsych.2009.08.039 · DOI
- Martucci, 2006, N-Methyl-d-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: polymorphisms and mRNA levels, Schizophr. Res., 84, 214, 10.1016/j.schres.2006.02.001 · DOI
- Javitt, 2015, Neurophysiological models for new treatment development in schizophrenia: early sensory approaches, Ann. N. Y. Acad. Sci., 1344, 92, 10.1111/nyas.12689 · DOI
- Naatanen, 2009, Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review, Int. J. Neuropsychopharmacol., 12, 125, 10.1017/S1461145708009322 · DOI · Paper page
- Lisman, 2010, A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia, Biol. Psychiatry, 68, 17, 10.1016/j.biopsych.2010.04.007 · DOI · Paper page
- Weickert, 2013, Molecular evidence of N-methyl-d-aspartate receptor hypofunction in schizophrenia, Mol. Psychiatry, 18, 1185, 10.1038/mp.2012.137 · DOI · Paper page
- Law, 2001, Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses, Neuroreport, 12, 2971, 10.1097/00001756-200109170-00043 · DOI · Paper page
- Papaleo, 2012, Mouse models of genetic effects on cognition: relevance to schizophrenia, Neuropharmacology, 62, 1204, 10.1016/j.neuropharm.2011.04.025 · DOI
- Rotaru, 2012, The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia, Rev. Neurosci., 23, 97, 10.1515/revneuro-2011-0059 · DOI · Paper page
- Tandon, 2009, Schizophrenia, “just the facts” 4. Clinical features and conceptualization, Schizophr. Res., 110, 1, 10.1016/j.schres.2009.03.005 · DOI · Paper page
- Buckley, 2001, Potassium channel antibodies in two patients with reversible limbic encephalitis, Ann. Neurol., 50, 73, 10.1002/ana.1097 · DOI · Paper page
- Lai, 2009, AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location, Ann. Neurol., 65, 424, 10.1002/ana.21589 · DOI · Paper page
- Petit-Pedrol, 2014, Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterization of the antigen, and analysis of the effects of antibodies, Lancet Neurol., 13, 276, 10.1016/S1474-4422(13)70299-0 · DOI · Paper page
- Bien, 2012, Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis, Brain, 135, 1622, 10.1093/brain/aws082 · DOI · Paper page
- Camdessanche, 2011, Brain immunohistopathological study in a patient with anti-NMDAR encephalitis, Eur. J. Neurol., 18, 929, 10.1111/j.1468-1331.2010.03180.x · DOI
- Martinez-Hernandez, 2011, Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis, Neurology, 77, 589, 10.1212/WNL.0b013e318228c136 · DOI · Paper page
- Lim, 2015, Autoimmune encephalopathies, Pediatr. Clin. North Am., 62, 667, 10.1016/j.pcl.2015.03.011 · DOI
- Gleichman, 2012, Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain, J. Neurosci., 32, 11082, 10.1523/JNEUROSCI.0064-12.2012 · DOI · Paper page
- Gresa-Arribas, 2014, Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study, Lancet Neurol., 13, 167, 10.1016/S1474-4422(13)70282-5 · DOI · Paper page
- Moscato, 2014, Acute mechanisms underlying antibody effects in anti-N-methyl-d-aspartate receptor encephalitis, Ann. Neurol., 76, 108, 10.1002/ana.24195 · DOI · Paper page
- Planaguma, 2015, Human N-methyl-d-aspartate receptor antibodies alter memory and behaviour in mice, Brain, 138, 94, 10.1093/brain/awu310 · DOI · Paper page
- Rose, 1993, Defining criteria for autoimmune diseases (Witebsky's postulates revisited), Immunol. Today, 14, 426, 10.1016/0167-5699(93)90244-F · DOI · Paper page
- Pruss, 2010, Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin, Neurology, 75, 1735, 10.1212/WNL.0b013e3181fc2a06 · DOI · Paper page
- Dalmau, 2011, Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis, Lancet Neurol., 10, 63, 10.1016/S1474-4422(10)70253-2 · DOI · Paper page
- Hafner, 2013, ABC Schizophrenia study: an overview of results since 1996, Soc. Psychiatry Psychiatr. Epidemiol., 48, 1021, 10.1007/s00127-013-0700-4 · DOI
- Novotna, 2015, Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis, Neurology, 85, 722, 10.1212/WNL.0000000000001856 · DOI
- Lebon, 2012, Anti-N-methyl-d-aspartate (NMDA) receptor encephalitis mimicking a primary psychiatric disorder in an adolescent, J. Child Neurol., 27, 1607, 10.1177/0883073812438099 · DOI
- Tidswell, 2013, Early recognition of anti-N-methyl-d-aspartate (NMDA) receptor encephalitis presenting as acute psychosis, Australas Psychiatry, 21, 596, 10.1177/1039856213506502 · DOI
- Barry, 2011, Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis, Br. J. Psychiatry, 199, 508, 10.1192/bjp.bp.111.092197 · DOI
- Knight, 2007, Rationale for a trial of immunosuppressive therapy in acute schizophrenia, Mol. Psychiatry, 12, 424, 10.1038/sj.mp.4001959 · DOI
- Saetre, 2007, Inflammation-related genes up-regulated in schizophrenia brains, BMC Psychiatry, 7, 46, 10.1186/1471-244X-7-46 · DOI · Paper page
- Bloomfield, 2016, Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [11C]PBR28 PET brain imaging study, Am. J. Psychiatry, 173, 44, 10.1176/appi.ajp.2015.14101358 · DOI · Paper page
- Pollak, 2014, Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis, Psychol. Med., 44, 2475, 10.1017/S003329171300295X · DOI · Paper page
- Tsutsui, 2012, Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features, BMC Psychiatry, 12, 37, 10.1186/1471-244X-12-37 · DOI · Paper page
- Ransohoff, 2012, The anatomical and cellular basis of immune surveillance in the central nervous system, Nat. Rev. Immunol., 12, 623, 10.1038/nri3265 · DOI · Paper page
- Leypoldt, 2015, Autoimmune encephalopathies, Ann. N. Y. Acad. Sci., 1338, 94, 10.1111/nyas.12553 · DOI · Paper page
- Zandi, 2015, N-Methyl-d-aspartate receptor autoantibodies in psychiatric illness, Biol. Psychiatry
- Joubert, 2015, Clinical spectrum of encephalitis associated with antibodies against the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature, JAMA Neurol., 72, 1163, 10.1001/jamaneurol.2015.1715 · DOI
- Bataller, 2010, Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor, Neurology, 74, 265, 10.1212/WNL.0b013e3181cb3e52 · DOI
- Lancaster, 2011, Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome, Neurology, 77, 1698, 10.1212/WNL.0b013e3182364a44 · DOI · Paper page
- Jarius, 2015, Psychotic syndrome associated with anti-Ca/ARHGAP26 and voltage-gated potassium channel antibodies, J. Neuroimmunol., 286, 79, 10.1016/j.jneuroim.2015.07.009 · doi:10.1016/j.jneuroim.2015.07.009
- Hedegaard, 2012, Molecular pharmacology of human NMDA receptors, Neurochem. Int., 61, 601, 10.1016/j.neuint.2011.11.016 · DOI
- Zandi, 2015, Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes, J. Neurol. Neurosurg. Psychiatry, 86, 708, 10.1136/jnnp-2014-308736 · DOI
- Najjar, 2013, Neuropsychiatric autoimmune encephalitis without VGKC-complex, NMDAR, and GAD autoantibodies: case report and literature review, Cogn. Behav. Neurol., 26, 36, 10.1097/WNN.0b013e31828b6531 · DOI
- Ellaithy, 2015, Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment, Trends Neurosci., 38, 506, 10.1016/j.tins.2015.06.002 · DOI
- Banerjee, 2015, Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia, Mol. Psychiatry, 20, 1091, 10.1038/mp.2014.115 · DOI · Paper page
- Pitcher, 2011, Schizophrenia susceptibility pathway neuregulin 1–ErbB4 suppresses Src upregulation of NMDA receptors, Nat. Med., 17, 470, 10.1038/nm.2315 · DOI · Paper page
- Hahn, 2006, Altered neuregulin 1–erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia, Nat. Med., 12, 824, 10.1038/nm1418 · DOI · Paper page
- Labrie, 2010, The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia, Neurosci. Biobehav. Rev., 34, 351, 10.1016/j.neubiorev.2009.08.002 · DOI
- Watabe-Uchida, 2012, Whole-brain mapping of direct inputs to midbrain dopamine neurons, Neuron, 74, 858, 10.1016/j.neuron.2012.03.017 · DOI · Paper page
- Kodangattil, 2013, Spike timing-dependent plasticity at GABAergic synapses in the ventral tegmental area, J. Physiol., 591, 4699, 10.1113/jphysiol.2013.257873 · DOI
- Olson, 2007, Topographical organization of GABAergic neurons within the ventral tegmental area of the rat, Synapse, 61, 87, 10.1002/syn.20345 · DOI · Paper page
- Tatard-Leitman, 2015, Pyramidal cell selective ablation of N-methyl-d-aspartate receptor 1 causes increase in cellular and network excitability, Biol. Psychiatry, 77, 556, 10.1016/j.biopsych.2014.06.026 · DOI · Paper page
- Hafner, 1995, Epidemiology of early-onset schizophrenia, Eur. Arch. Psychiatry Clin. Neurosci., 245, 80, 10.1007/BF02190734 · DOI · Paper page
- Graus, 2001, Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients, Brain, 124, 1138, 10.1093/brain/124.6.1138 · DOI · Paper page
Cited by
Dalmau, J., Armangué, T., Planagumà, J., Radosevic, M., Mannara, F., Leypoldt, F., Geis, C., Lancaster, E., Titulaer, M. J., Rosenfeld, M. R., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30244-3 · Cited by 899
Self-citationDalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Self-citationPollak, T. A., Lennox, B. R., Müller, S., Benros, M. E., Prüss, H., Tebartz van Elst, L., Klein, H., Steiner, J., Frodl, T., Bogerts, B., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30290-1 · Cited by 402
The origin of NMDA receptor hypofunction in schizophrenia
Nakazawa, K., & Sapkota, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107426 · Cited by 275
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
Carvalho, A. F., Solmi, M., Sanches, M., Machado, M. O., Stubbs, B., Ajnakina, O., Sherman, C., Sun, Y. R., Liu, C. S., Brunoni, A. R., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0835-5 · Cited by 204
Metadata
- Authors
- Masdeu, J. C., Dalmau, J., & Berman, K. F.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 39
- Issue
- 5
- Pages
- 300-310
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W2343055661
- Cited by
- 91
- References
- 41
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.